Global Oral Thin Films Market: Industry Analysis and forecast (2019 to 2026)

Global Oral Thin Films Market was valued US$ XX Mn in 2018 and is expected to reach US$ XX Mn by 2026, at CAGR of XX% during forecast period of 2019 to 2026.

 

Global Oral Thin Films Market

 

Global Oral Thin Films Market Drivers and Restrains:

Oral film is made up of hydrophilic polymers that quickly dissolves on the tongue or buccal cavity, delivering the drug to the systemic circulation via dissolution when contact with liquid is made. Oral thin films has several advantages such as fast onset of action, ease of transportation, bypassing hepatic first pass effect, and handling, these offers to high bioavailability and rapid absorption for drugs. Sublingual oral thin film is a better alternative for tablets, as it provides complete drug delivery for quick relief.The report study has analyzed revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis.

People with a swallowing difficulty to require oral administration of drugs. Therefore, oral thin film medication is developed for swift oral administration of drugs. To improve patient compliance various types of vaccines and hormones are developed by the market players. The use of oral thin films for preventing gastrointestinal degradation of acid sensitive drugs will drive the global market

Expensive cost of treatments involving oral thin films, the requirement of vast research investment and challenges related to drug development are hampering the market growth at global level. Both startups and established players in the pharmaceutical industry have been showing great interest in oral thin films. Various advantages of oral thin films are foreseen to create a large consumer base for vendors functioning in the market.

 

Global Oral Thin Films Market Segmentation Analysis:

Based on disease indication, the global oral thin films market has been segmented into schizophrenia, opioid dependence, migraine, and nausea & vomiting. The schizophrenia segment dominated the global market in 2018. The trend is anticipated to continue during the forecast period. Schizophrenia is a mental disorder that typically looks in late adolescence or early adulthood. On other hand, the opioid dependence is likely to be the second largest segment in terms of market share during the forecast period owing to increase in number of people suffering from opioid dependence.

 

Global Oral Thin Films Market Regional Analysis:

Geographically, the oral thin films market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held the largest market share in 2018 owing to presence of key players in the region, increase in research and development activities and new drug approvals. Easy access and early adoption of novel drug technology and change in trend from oral tablets to oral thin films is expected to fuel the market in North America. Furthermore, The U.S. accounts for significant share of the market in North America due to major pharmaceutical companies are presence in the U.S. The rising adoption rate of oral thin films in U.S. market as compared to Europe oral thin films market is attributed to initial introduction of technology in U.S. Moreover, rise in awareness about the latest health care technologies for disease diagnosis and treatment, high purchasing power, and affordability of products are projected to boost demand for oral thin films in various applications.

 

Global Oral Thin Films Market Competitive landscape

Major Key players operating in this market are MonoSol Rx, Tesa Labtec GmbH, Pfizer, Inc., Nvartis AG, Wolters Kluwer. Manufacturers in the oral thin films are focusing on competitive pricing as the strategy to capture significant market share. Moreover, strategic mergers and acquisitions and technological innovations are also the key focus areas of the manufacturers.

 

The objective of the report is to present comprehensive analysis of global oral thin films market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers the all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding global oral thin films market dynamics, structure by analyzing the market segments, and project the global oral thin films market size. Clear representation of competitive analysis of key players by drug class, price, financial position, product portfolio, growth strategies, and regional presence in the global oral thin films market make the report investor’s guide.

Scope of the Global Oral Thin Films Market:

 

Global Oral Thin Films Market, by Product:

 

• Oral Thin Film

• Sublingual Film

• Fully Dissolving Dental/Buccal Film

• Transdermal Thin Film

Global Oral Thin Films Market, by Disease Indication:

 

• Schizophrenia

• Migraine

• Opioid Dependence

• Nausea and Vomiting

Global Oral Thin Films Market, by Distribution Channel:

 

• Hospital Pharmacies

• Drug Stores

• Retail Pharmacies

• E-commerce

Global Oral Thin Films Market, by Region:

 

• Asia Pacific

• North America

• Europe

• Latin America

• Middle East Africa

Global Oral Thin Films Market, Major Players:

 

• MonoSol Rx

• Tesa Labtec GmbH

• Pfizer, Inc.

• Novartis AG

• Wolters Kluwer

• Solvay

• Allergan plc.

• Sumitomo Dainippon Pharma Co.Ltd.

• IntelGenx Corp.

• Transition Therapeutics, Inc.

• ZIM Laboratories Limited

• Indivior plc

• Aquestive Therapeutics, Inc.

• NAL Pharma

For More Information Visit @: Maximize Market Research Company

This Report Is Submitted By : Maximize Market Research Company

Customization of the report:

Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.

 

About Maximize Market Research:

Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Lumawant Godage

Organization Address: MAXIMIZE MARKET RESEARCH PVT. LTD.

Email: sales@maximizemarketresearch.com

Address: Pune, Maharashtra 411051, India.

Contact: +919607195908

 


More Info

Leave a Reply

Your email address will not be published. Required fields are marked *